These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 9440761)

  • 1. Human papillomaviruses and associated malignancies.
    Alani RM; Münger K
    J Clin Oncol; 1998 Jan; 16(1):330-7. PubMed ID: 9440761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity.
    Hebner CM; Laimins LA
    Rev Med Virol; 2006; 16(2):83-97. PubMed ID: 16287204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.
    zur Hausen H
    J Natl Cancer Inst; 2000 May; 92(9):690-8. PubMed ID: 10793105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of the human papilloma virus in relation to cancer.
    Wu TC
    Curr Opin Immunol; 1994 Oct; 6(5):746-54. PubMed ID: 7826530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and pathological associations of the human papillomaviruses: a review.
    Cheah PL; Looi LM
    Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of human papillomavirus in carcinogenesis of cervical cancer and vaccination for HPV].
    Kariya M; Fujii S
    Uirusu; 2002 Dec; 52(2):287-93. PubMed ID: 12685321
    [No Abstract]   [Full Text] [Related]  

  • 7. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections.
    von Knebel Doeberitz M
    Eur J Cancer; 2002 Nov; 38(17):2229-42. PubMed ID: 12441259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillomaviruses in human disease: Part II. Molecular biology and immunology of papillomavirus infections and carcinogenesis.
    von Knebel Doeberitz M
    Eur J Med; 1992 Dec; 1(8):485-91. PubMed ID: 1341208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus and cervical carcinogenesis.
    Stanley MA
    Best Pract Res Clin Obstet Gynaecol; 2001 Oct; 15(5):663-76. PubMed ID: 11563866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
    de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
    Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccines for cervical cancer: from bench to bedside.
    Hung CF; Monie A; Alvarez RD; Wu TC
    Exp Mol Med; 2007 Dec; 39(6):679-89. PubMed ID: 18160838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV: Molecular pathways and targets.
    Gupta S; Kumar P; Das BC
    Curr Probl Cancer; 2018; 42(2):161-174. PubMed ID: 29706467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomaviruses in epigenetic regulations.
    Durzynska J; Lesniewicz K; Poreba E
    Mutat Res Rev Mutat Res; 2017; 772():36-50. PubMed ID: 28528689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human papillomaviruses, cell cycle and cervical cancer].
    Mougin C; Humbey O; Gay C; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):13-20. PubMed ID: 10675829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
    Belcastro M; Miller MR; Flynn DC; Soisson AP
    Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.